Sugi Predict

Sugi Predict / Compounds / SCHEMBL238714

SCHEMBL238714

SCHEMBL238714

O=C(O)Cc1cc[c]cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKR1B1 P15121 1/20 0.61
▸ CA2 P00918 2/20 0.56
▸ CAMK2A Q9UQM7 1/20 0.56
▸ LMNA P02545 2/20 0.52
▸ GAA P10253 2/20 0.52
▸ TSHR P16473 2/20 0.52
▸ ABCC4 O15439 1/20 0.52
▸ PTGS1 P23219 1/20 0.52
▸ HTT P42858 1/20 0.52
▸ ALDH1A1 P00352 3/20 0.47
▸ HPGD P15428 3/20 0.47
▸ HSD17B10 Q99714 3/20 0.47
▸ FFAR1 O14842 1/20 0.47
▸ POLB P06746 2/20 0.45
▸ NSD2 O96028 1/20 0.45
▸ GRK2 P25098 1/20 0.45
▸ CASP6 P55212 1/20 0.45
▸ CTDSP1 Q9GZU7 1/20 0.45
▸ KDM4E B2RXH2 2/20 0.45
▸ MAPT P10636 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5780595 0.84 CYP4F2 (0.51) AKR1B1CA2CAMK2ALMNAGAA
SCHEMBL22637979 0.82 CA2 (0.48) AKR1B1CA2CAMK2ALMNAGAA
SCHEMBL240565 0.82 FFAR1 (0.70) AKR1B1CA2CAMK2ALMNAGAA
SCHEMBL22637978 0.82 CA2 (0.48) AKR1B1CA2CAMK2ALMNAGAA
SCHEMBL69614 0.81 CA2 (0.79) AKR1B1CA2CAMK2ALMNAGAA
Phenylacetic Acid SCHEMBL10524559 0.79 AKR1B1 (0.94) AKR1B1CA2CAMK2ALMNAGAA
SCHEMBL1727676 0.79 CES2 (0.35) AKR1B1CA2CAMK2ALMNAGAA
Phenylacetic Acid SCHEMBL27273848 0.79 AKR1B1 (0.94) AKR1B1CA2CAMK2ALMNAGAA
Hydrochloric Acid SCHEMBL25180348 0.78 CA2 (0.75) AKR1B1CA2CAMK2ALMNAGAA
Hydrochloric Acid SCHEMBL6765874 0.78 CA2 (0.75) AKR1B1CA2CAMK2ALMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230348694-A1 SHELF LIFE- AND TRANSPORT STABILIZERS FOR POLYMERIZABLE COMPOUNDS BASF SE (DE) 2023-11-02 — — US claimed
WO-2023109254-A1 METHOD FOR ONE-STEP DIRECT PREPARATION OF 3-ACYL IMIDAZO[1,5-A]PYRIDINE BY MEANS OF [4+1] DUAL AMINATION REACTIONS OF KETOMETHYL 安徽科技学院 2023-06-22 — — WO claimed
CN-114057737-B Method for directly preparing 3-acyl imidazole [1,5-a ] pyridine by one-step secondary amination reaction of [4+1] ketone methyl 安徽科技学院 2022-08-26 — — CN claimed
CN-114746390-A Storage and transport stabilizers for polymerizable compounds 巴斯夫欧洲公司 2022-07-12 — — CN claimed
CN-114057737-A Method for directly preparing 3-acyl imidazole [1,5-a ] pyridine by one-step secondary amination reaction of [4+1] ketone methyl 安徽科技学院 2022-02-18 — — CN claimed
WO-2021105038-A1 SHELF LIFE- AND TRANSPORT STABILIZERS FOR POLYMERIZABLE COMPOUNDS BASF SE (DE) 2021-06-03 — — WO claimed
US-20210052561-A1 TARGETING ASPARTATE BETA-HYDROXYLASE SUPPRESSES TUMOR MALIGNANCY AND METASTASIS MIDWESTERN UNIVERSITY 2021-02-25 — — US claimed
US-20200361925-A1 INHIBITORS OF BETA-HYDROXYLASE FOR TREATMENT OF CANCER RHODE ISLAND HOSPITAL (US) 2020-11-19 — — US claimed
US-10710995-B2 Inhibitors of β-hydroxylase for treatment of cancer RHODE ISLAND HOSPITAL (US) 2020-07-14 — — US claimed
US-20190225611-A1 SUBSTITUTED SPIROCYCLIC INHIBITORS OF AUTOTAXIN X-RX, INC. 2019-07-25 — — US claimed
US-5409620-A Fiber treatment compositions containing organofunctional siloxanes and methods for the preparation thereof DOW CORNING CORPORATION (US) 1995-04-25 — — US claimed
EP-0635263-A2 Angiotensin (AII) antagonists as inhibitors of the growth of adipose tissue AMERICAN CYANAMID COMPANY (US) 1995-01-25 — — EP claimed
EP-0505413-B1 BETA-LACTAM DERIVATIVES ERBA CARLO SPA (IT) 1994-08-31 — — EP claimed
EP-0505413-A1 BETA-LACTAM DERIVATIVES. ERBA FARMITALIA (IT) 1992-09-30 — — EP claimed
WO-1991009036-A1 BETA-LACTAM DERIVATIVES FARMITALIA CARLO ERBA S.R.L. (IT) 1991-06-27 — — WO claimed
CN-1042153-A 3-aryloxy methyl-cephalosporins derivatives, their preparation and purposes pharmaceutically SANKYO CO (JP) 1990-05-16 — — CN claimed
EP-0363223-A2 3-Aryloxymethyl-cephalosporin derivatives, their preparation and their medical use Sankyo Company Limited (JP) 1990-04-11 — — EP claimed
US-4598033-A IMPROVED SENSITIVITY AND DURAVILITY FUJI PHOTO FILM CO., LTD. (JP) 1986-07-01 — — US claimed
US-4276295-A VASODILATORS, HYPOTENSIVE, ANTIATHEROSCLEROTIC Ishikawa, Masayuki (JP) 1981-06-30 — — US claimed
US-4182897-A ENZYME INHIBITORS FOR PROTEOLYTIC ENZYMES TORII & CO., LTD. (JP) 1980-01-08 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210052561-A1 TARGETING ASPARTATE BETA-HYDROXYLASE SUPPRESSES TUMOR MALIGNANCY AND METASTASIS ASPH, GOT1, FOLH1 AKR1B1 93/4885CA2 1512/4885CAMK2A 1245/4885
US-20190225611-A1 SUBSTITUTED SPIROCYCLIC INHIBITORS OF AUTOTAXIN ENPP2, SLC10A1, CXCR3 AKR1B1 538/4885CA2 2783/4885CAMK2A 2183/4885
US-10710995-B2 Inhibitors of β-hydroxylase for treatment of cancer ASPH, CYP46A1, AHR AKR1B1 10/4885CA2 2679/4885CAMK2A 3158/4885
US-20200361925-A1 INHIBITORS OF BETA-HYDROXYLASE FOR TREATMENT OF CANCER ASPH, CYP46A1, ALDH7A1 AKR1B1 13/4885CA2 2695/4885CAMK2A 3425/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.